Biolargo, INC. (BLGO) — 10-Q Filings

10-Q Filings (6)

• BioLargo's Net Loss Widens to $11M Amidst Revenue Plunge, Credit Loss — Nov 14, 2025 Risk: high
  BIOLARGO, INC. (BLGO) reported a significant net loss of $11.047 million for the nine months ended September 30, 2025, a substantial increase from the $2.615 mi
• BioLargo's Revenue Plummets, Net Loss Widens Amid Going Concern Doubts — Aug 14, 2025 Risk: high
  BIOLARGO, INC. (BLGO) reported a significant decline in revenue and an increased net loss for the six months ended June 30, 2025. Total revenue decreased by 38.
• BioLargo Reports Q1 2025 Results: Assets Up, Net Loss Continues — May 15, 2025 Risk: medium
  BioLargo, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $301,760,373 as of March 31, 2025, a slight increase fr
• BioLargo Reports Q3 2024 Financials — Nov 14, 2024 Risk: high
  BioLargo, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported total assets of $301,163,538 and total liabilities of $292,945,747
• BioLargo Reports Q2 2024 Results: Net Loss and Liabilities — Aug 14, 2024 Risk: high
  BioLargo, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported total assets of $5,562,754 and total liabilities of $10,374,635. For the
• BioLargo, Inc. Files 10-Q for Period Ending March 31, 2024 — May 14, 2024 Risk: medium
  BIOLARGO, INC. (BLGO) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. BioLargo, Inc. reported a net loss of ($1,057,605) for the three months ende

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX